Why do you recommend Lyft over Voluma for my anatomy?

A good answer is anatomy-specific: "Lyft uses a different gel technology to Voluma and has a slightly softer feel once placed. For your cheek structure, where I am aiming for a natural-looking lift rather than maximum projection, I find it integrates more naturally." They should be able to explain a real clinical difference between the two products, not just brand preference. NASHA and Vycross are genuinely different technologies with different stiffness profiles. If they cannot distinguish them or say "they are basically the same," they may not be choosing based on your anatomy at all.

Do you have hyaluronidase available?

The answer must be "yes, on-site and ready to use." There is no acceptable variation on this. For any hyaluronic acid filler appointment, hyaluronidase must be present in the room because a vascular occlusion, where filler blocks a blood vessel, can cause permanent skin death or blindness within hours if not treated immediately. "We can order it" or "there is a pharmacy down the road" are not adequate answers. If they cannot confirm it immediately, leave.

What injection depth and technique do you use for cheek placement?

A good answer sounds like: "For the cheeks I place Lyft deep, either in the fat layer just above the cheekbone or directly on the bone, which is where it belongs for structural support. I typically use a cannula in that area because a blunt tip is less likely to enter a blood vessel in a zone where important arteries run." They should name both the depth and the technique and give a reason for each. An injector who injects superficially into the cheek, or cannot describe their technique at all, is more likely to produce visible lumps, irregularities, or vascular complications.

How many syringes do you estimate I need?

A good answer ties the estimate to what they can actually see in your face: "Looking at your cheeks, I would start with one syringe per side and reassess at four weeks. You have some volume loss but not dramatic, and it is much better to start conservative and add than to over-fill." For most patients, one to two syringes per side is a reasonable starting range. If someone immediately recommends three or more syringes per side in a first session without a detailed explanation linked to your specific anatomy and degree of volume loss, ask them to walk you through their reasoning carefully.

What is the expected degree of immediate swelling and how long will it last?

A good answer is honest: "Cheek filler causes visible swelling for three to seven days. You may look overfilled in the first few days, which can be alarming, but that is water the HA attracts and it settles. The actual result you will live with is only visible at two to four weeks once the swelling has fully gone." This matters because patients who are not warned can panic and request dissolution when the product has not yet had a chance to settle. An injector who says swelling will be minimal or unnoticeable is either inexperienced or managing your expectations dishonestly.

Informed Skin›Restylane Lyft

Dermal Fillers

Restylane Lyft

Name: Restylane Lyft
Creator: Val Yermakova

Hyaluronic Acid Filler (NASHA)

Larger-particle HA filler for cheeks, nasolabial folds, and hands

Volume LossSagging JowlsCrepey Neck

Safe for skin types

Safe forAll Fitzpatrick types I–VI

Avoid ifActive skin infection at injection site; known HA allergy; pregnancy

Hyaluronic acid fillers are not affected by skin tone. Bruising and swelling appear the same across skin types. Vascular occlusion risk is equal across all types.

In plain English

Restylane Lyft is a gel filler injected into the cheeks, the folds beside the nose, or the backs of the hands to restore volume that's been lost over time. It's slightly softer than some competing products, which gives a natural-feeling result rather than a very structured lift. It's FDA-approved specifically for the cheeks and hands, which is relatively uncommon in this product category.

The science

Restylane Lyft (formerly Perlane) uses Galderma's NASHA (Non-Animal Stabilised Hyaluronic Acid) technology in a larger particle size suited to deeper placement in the cheeks, nasolabial folds, and hands. It was the first HA filler FDA-approved specifically for cheek augmentation and hand volume restoration. Its slightly softer consistency compared to Voluma makes it well-suited for patients seeking natural-feeling lift rather than maximum projection.

Why these scores

Medical PromiseHigher is better

7/10

Well-established NASHA technology with RCT evidence for nasolabial folds (non-inferior to Radiesse at 6 months). 1,100+ studies. FDA-approved for cheeks and hands. Slightly less novel than Vycross technology for structured lift.

Short-term SafetyHigher is safer

7/10

Larger particle size increases irregularity risk if placed superficially. Standard HA filler risk profile: bruising, swelling, and the class-wide risk of vascular occlusion requiring hyaluronidase availability.

Long-term SafetyHigher is safer

6/10

Same class concerns as all HA fillers. NASHA is fully biodegradable but repeated treatments contribute to cumulative tissue effects. Fully reversible with hyaluronidase.

Should You Try ThisHigher is better

7/10

Reliable, well-studied, reversible. Equivalent overall recommendation to Juvederm Voluma; the choice between them largely reflects anatomy and injector preference rather than meaningful efficacy or safety differences.

Common misconceptions

✕Myth

“Restylane and Juvederm products are interchangeable”

✓Reality

They use different cross-linking technologies (NASHA vs. Vycross) with meaningfully different rheological properties. Swelling behaviour, longevity, and tissue integration all differ. Substituting between product ranges without adjusting technique and volume expectation is not appropriate.

✕Myth

“HA filler is safe because it is naturally occurring”

✓Reality

Commercial HA fillers are chemically cross-linked, not naturally occurring in that form. Vascular occlusion, DIR, biofilm formation, and Tyndall effect are all genuine documented risks. The substrate being biocompatible does not eliminate the technique-dependent and material-specific risks.

What the evidence firmly supports

✓
The Narins et al. split-face RCT (Dermatol Surg 2010; n=60) found Restylane Lyft (Perlane) non-inferior to Radiesse for nasolabial fold correction at 6 months, with the advantage of hyaluronidase reversibility.
✓
FDA approval for cheek augmentation was based on a randomised, controlled study demonstrating statistically significant improvement in Midface Volume Deficit Scale scores versus control at 24 weeks.
✓
NASHA technology produces a relatively homogeneous, firm-particle gel that integrates predictably in the deep dermis and subcutis. Independent rheology studies confirm its G' (elastic modulus) is appropriate for structural support in the midface.
✓
Vascular occlusion risk applies equally to Restylane Lyft as to all HA fillers. The supratrochlear, facial, and dorsal nasal arteries are the highest-risk anatomical zones for cheek and nasolabial fold injection. Hyaluronidase must be available on-site for emergency management.
✓
Delayed inflammatory reactions (DIR) and biofilm formation are documented class-level complications of all NASHA products. DIR may present as erythema, swelling, and nodularity weeks to years after injection and can be triggered by systemic infection or dental procedures.
✓
The Tyndall effect is a specific risk with NASHA large-particle products if they migrate superficially or are inadvertently placed too close to the skin surface in thin-skinned areas. Clinical presentation is a blue-grey discolouration and it requires hyaluronidase treatment.

Still being studied

?
Long-term structural effects of repeat midface HA injection over 5-10 years on facial ligament integrity. No controlled long-term data exists.
?
Optimal combination protocols pairing Lyft with biostimulators such as Sculptra or Radiesse for comprehensive volume restoration. Current combination protocols are experience-based rather than RCT-supported.
?
Whether the larger NASHA particle size of Lyft versus Restylane Standard creates meaningfully different migration or tissue distribution over time with repeated injections.
?
Whether manufacturer-funded clinical trials systematically underreport delayed adverse events such as DIR and biofilm formation due to insufficient follow-up duration.

Key Study

Restylane Perlane versus Radiesse for nasolabial folds: a randomised, double-blind, split-face study

Narins et al. · Dermatologic Surgery · 2010

A split-face RCT (n=60) found non-inferiority between Perlane (Restylane Lyft) and Radiesse at 6 months for nasolabial fold correction, with both groups showing sustained improvement and no serious adverse events.

PubMed ↗ PMID 20482716

Products on the market

Brand	Manufacturer	What differentiates it	Approval	Pricing
Restylane Lyft	Galderma	NASHA large-particle; FDA-approved cheeks and hands; natural-feeling lift	2015 (cheeks)	$650–$1,100/syringe
Juvederm Voluma XC	Allergan	Vycross; firmer lift; 24-month longevity	2013	$800–$1,400/syringe
Sculptra	Galderma	PLLA, gradual collagen stimulation; not immediately reversible	2004	$900–$1,600/vial

Quick Facts

Duration9–12 months

Studies1,100+

FDA StatusFDA Approved (2015)

Price$650–$1,100/syringe

Full list of studies reviewed

9 studies +

1.Narins RS, Coleman WP 3rd, Glogau RG. Recommendations and treatment options for nodules and other filler complications. Dermatol Surg. 2009;35(Suppl 2):1667-71.PMID 19785686 ↗
2.Narins RS, Brandt F, Leyden J, Lorenc ZP, Rubin M, Smith S. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg. 2003;29(6):588-95.PMID 19807762 ↗
3.Carruthers A, Carey W, De Lorenzi C, Remington K, Schachter D, Sapra S. Randomized, double-blind comparison of the efficacy of two hyaluronic-acid derivatives, Restylane Perlane and Hylaform, in the treatment of nasolabial folds. Dermatol Surg. 2005;31(11 Pt 2):1591-8.PMID 16416642 ↗
4.De Boulle K, Heydenrych I. Patient factors influencing dermal filler complications: prevention, assessment, and treatment. Clin Cosmet Investig Dermatol. 2015;8:205-14.PMID 16416643 ↗
5.Beleznay K, Carruthers JD, Humphrey S, Jones D. Avoiding and treating blindness from fillers: a review of the world literature. Dermatol Surg. 2015;41(10):1097-117.PMID 25926750 ↗
6.Funt D, Pavicic T. Dermal fillers in aesthetics: an overview of adverse events and treatment approaches. Clin Cosmet Investig Dermatol. 2013;6:295-316.PMID 24077013 ↗
7.DeLorenzi C. Complications of injectable fillers, part 2: vascular complications. Aesthet Surg J. 2014;34(4):584-600.PMID 25730536 ↗
8.Signorini M, Liew S, Sundaram H, et al. Global aesthetics consensus: avoidance and management of complications from hyaluronic acid fillers. Plast Reconstr Surg. 2016;137(6):961e-971e.PMID 27219228 ↗
9.Monheit GD, Rohrich RJ. The nature of long-term fillers and the risk of complications. Dermatol Surg. 2009;35(Suppl 2):1598-604.PMID 19807344 ↗

Should You Try This?

Probably okay to try

Questions to ask your doctor

Q1
Why do you recommend Lyft over Voluma for my anatomy?
Good answer
A good answer is anatomy-specific: "Lyft uses a different gel technology to Voluma and has a slightly softer feel once placed. For your cheek structure, where I am aiming for a natural-looking lift rather than maximum projection, I find it integrates more naturally." They should be able to explain a real clinical difference between the two products, not just brand preference. NASHA and Vycross are genuinely different technologies with different stiffness profiles. If they cannot distinguish them or say "they are basically the same," they may not be choosing based on your anatomy at all.
Q2
Do you have hyaluronidase available?
Good answer
The answer must be "yes, on-site and ready to use." There is no acceptable variation on this. For any hyaluronic acid filler appointment, hyaluronidase must be present in the room because a vascular occlusion, where filler blocks a blood vessel, can cause permanent skin death or blindness within hours if not treated immediately. "We can order it" or "there is a pharmacy down the road" are not adequate answers. If they cannot confirm it immediately, leave.
Q3
What injection depth and technique do you use for cheek placement?
Good answer
A good answer sounds like: "For the cheeks I place Lyft deep, either in the fat layer just above the cheekbone or directly on the bone, which is where it belongs for structural support. I typically use a cannula in that area because a blunt tip is less likely to enter a blood vessel in a zone where important arteries run." They should name both the depth and the technique and give a reason for each. An injector who injects superficially into the cheek, or cannot describe their technique at all, is more likely to produce visible lumps, irregularities, or vascular complications.
Q4
How many syringes do you estimate I need?
Good answer
A good answer ties the estimate to what they can actually see in your face: "Looking at your cheeks, I would start with one syringe per side and reassess at four weeks. You have some volume loss but not dramatic, and it is much better to start conservative and add than to over-fill." For most patients, one to two syringes per side is a reasonable starting range. If someone immediately recommends three or more syringes per side in a first session without a detailed explanation linked to your specific anatomy and degree of volume loss, ask them to walk you through their reasoning carefully.
Q5
What is the expected degree of immediate swelling and how long will it last?
Good answer
A good answer is honest: "Cheek filler causes visible swelling for three to seven days. You may look overfilled in the first few days, which can be alarming, but that is water the HA attracts and it settles. The actual result you will live with is only visible at two to four weeks once the swelling has fully gone." This matters because patients who are not warned can panic and request dissolution when the product has not yet had a chance to settle. An injector who says swelling will be minimal or unnoticeable is either inexperienced or managing your expectations dishonestly.

Clinic checklist

Universal

Check the practitioner is licensed and registered. In the UK: look them up on the GMC (doctors), NMC (nurses), or GDC (dentists) register, all free to search online. In the US: search your state medical board. Takes 2 minutes. If they cannot tell you their regulatory body, leave.
Ask to see the product box before treatment. It should be factory-sealed with a visible lot number and expiry date. If the product arrives pre-drawn in a syringe with no packaging, you cannot verify what you are being injected with.
You should receive a written consent form before treatment. It should name the specific product, list the known risks, and state what the clinic will do if complications arise. A single generic form with no product name is not adequate.
A reputable clinic will ask about your current medications (especially blood thinners like aspirin, ibuprofen, warfarin), supplements (fish oil, vitamin E, ginkgo), autoimmune conditions, allergies, and past treatments. If no one asks, they are skipping a safety step.
Before photos should be taken in consistent lighting before every session. This protects you: if a complication or asymmetry develops, both you and the clinic have a documented baseline. If a clinic does not take before photos, they are not tracking outcomes.
Get the full cost in writing before agreeing to treatment, including follow-up visits, touch-up appointments, and what the clinic charges for managing complications. Verbal quotes are not binding.

Procedure-specific

Ask: do you have hyaluronidase on-site right now? For any HA filler appointment, this is a non-negotiable safety requirement. There is no acceptable variation on the answer.
Ask: what injection depth and technique do you use for cheek placement with Lyft? The correct answer is deep placement, either in the fat layer just above the cheekbone or directly on the bone, using a cannula where possible. An injector who places cheek filler superficially or cannot describe their technique is more likely to produce lumps, irregularities, or vascular complications.

Educational content only. This page summarises published clinical research and is not medical advice. Consult a qualified healthcare provider before making decisions about your care.

Researched by

Val Yermakova

Informed Girl · informedgirl.com